Literature DB >> 15039322

The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages.

Oyebode Olakanmi1, Larry S Schlesinger, Ambar Ahmed, Bradley E Britigan.   

Abstract

We have reported that Mycobacterium tuberculosis residing within the phagosomes of human monocyte-derived macrophages (MDM) can acquire Fe from extracellular transferrin (TF) and sources within the MDM. In the lung, Fe is also bound to lactoferrin (LF) and low-molecular-weight chelates. We therefore investigated the ability of intraphagosomal M. tuberculosis to acquire Fe from these sources. M. tuberculosis acquired 30-fold and 3-fold more Fe from LF and citrate, respectively, compared to TF, in spite of similar MDM-associated Fe. M. tuberculosis infection decreased MDM-associated Fe relative to uninfected MDM as follows: TF (38.7%), citrate (21.1%), and LF (15.3%). M. tuberculosis Fe acquisition from extracellular chelates (exogenous source) and from endogenous MDM Fe initially acquired from the three chelates (endogenous source) was compared. M. tuberculosis Fe acquisition was similar from exogenous and endogenous sources supplied as Fe-TF. In contrast, there was much greater intracellular M. tuberculosis Fe uptake from LF and citrate from the exogenous than endogenous source. Gamma interferon (IFN-gamma) reduced MDM Fe uptake from each chelate by approximately 50% and augmented the M. tuberculosis-induced decrease in MDM Fe uptake from exogenous TF, but not from LF or citrate. IFN-gamma minimally decreased intracellular M. tuberculosis Fe acquisition from exogenous Fe-TF but significantly increased Fe uptake from LF and citrate. Intraphagosomal M. tuberculosis Fe acquisition from both exogenous and endogenous MDM sources, and the effect of IFN-gamma on this process, is influenced by the nature of the extracellular Fe chelate. M. tuberculosis has developed efficient mechanisms of acquiring Fe from a variety of Fe chelates that it likely encounters within the human lung.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039322      PMCID: PMC375202          DOI: 10.1128/IAI.72.4.2022-2028.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

Review 1.  The interaction of lactoferrin with human monocytes.

Authors:  H S Birgens
Journal:  Dan Med Bull       Date:  1991-06

2.  Characterization of a transferrin-independent uptake system for iron in HeLa cells.

Authors:  A Sturrock; J Alexander; J Lamb; C M Craven; J Kaplan
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

Review 3.  Microbial iron compounds.

Authors:  J B Neilands
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

4.  Effect of metabolic inhibitors on uptake of non-transferrin-bound iron by reticulocytes.

Authors:  Z M Qian; E H Morgan
Journal:  Biochim Biophys Acta       Date:  1991-04-09

5.  Non-transferrin dependent 59Fe uptake in phytohemagglutinin-stimulated human peripheral lymphocytes.

Authors:  S Hamazaki; J Glass
Journal:  Exp Hematol       Date:  1992-05       Impact factor: 3.084

6.  The uptake of inorganic iron complexes by human melanoma cells.

Authors:  D Richardson; E Baker
Journal:  Biochim Biophys Acta       Date:  1991-06-07

7.  Lower respiratory tract iron burden is increased in association with cigarette smoking.

Authors:  A B Thompson; T Bohling; A Heires; J Linder; S I Rennard
Journal:  J Lab Clin Med       Date:  1991-06

8.  Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.

Authors:  C R Chitambar; D Sax
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

9.  Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Regulation of the transferrin-independent iron transport system in cultured cells.

Authors:  J Kaplan; I Jordan; A Sturrock
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

View more
  19 in total

Review 1.  The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.

Authors:  Lawrence D Horwitz; Marcus A Horwitz
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

2.  Iron acquisition from transferrin by Candida albicans depends on the reductive pathway.

Authors:  Simon A B Knight; Gaston Vilaire; Emmanuel Lesuisse; Andrew Dancis
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake.

Authors:  Manjula Sritharan
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

4.  Host glyceraldehyde-3-phosphate dehydrogenase-mediated iron acquisition is hijacked by intraphagosomal Mycobacterium tuberculosis.

Authors:  Anil Patidar; Himanshu Malhotra; Surbhi Chaudhary; Manoj Kumar; Rahul Dilawari; Gaurav Kumar Chaubey; Asmita Dhiman; Radheshyam Modanwal; Sharmila Talukdar; Chaaya Iyengar Raje; Manoj Raje
Journal:  Cell Mol Life Sci       Date:  2022-01-09       Impact factor: 9.261

5.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

6.  Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig.

Authors:  Randall J Basaraba; Helle Bielefeldt-Ohmann; Ellie K Eschelbach; Claire Reisenhauer; Airn E Tolnay; Lauren C Taraba; Crystal A Shanley; Erin A Smith; Cathy L Bedwell; Elizabeth A Chlipala; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2007-10-17       Impact factor: 3.131

7.  Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes.

Authors:  Oyebode Olakanmi; Banurekha Kesavalu; Rajamouli Pasula; Maher Y Abdalla; Larry S Schlesinger; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

8.  Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model.

Authors:  Oyebode Olakanmi; John S Gunn; Shengchang Su; Shilpa Soni; Daniel J Hassett; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

9.  Profiling early lung immune responses in the mouse model of tuberculosis.

Authors:  Dongwan D Kang; Yinyao Lin; Javier-Rangel Moreno; Troy D Randall; Shabaana A Khader
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

Review 10.  Iron in intracellular infection: to provide or to deprive?

Authors:  Sandro Silva-Gomes; Sílvia Vale-Costa; Rui Appelberg; Maria S Gomes
Journal:  Front Cell Infect Microbiol       Date:  2013-12-09       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.